Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
KESTRA MEDICAL TECHNOLOGIES, LTD. market cap for the quarter ending 2026-09-11 was $1.36B, a 43.91% increase year-over-year.
KESTRA MEDICAL TECHNOLOGIES, LTD. market cap for the quarter ending 2026-07-31 was $1.35B, a 59.57% increase year-over-year.
KESTRA MEDICAL TECHNOLOGIES, LTD. market cap for the quarter ending 2026-07-09 was $1.57B, a 86.03% increase year-over-year.
KESTRA MEDICAL TECHNOLOGIES, LTD. market cap for the quarter ending 2026-04-30 was $1.21B.
KESTRA MEDICAL TECHNOLOGIES, LTD. market cap for fiscal 2026 was $1.36B.
KESTRA MEDICAL TECHNOLOGIES, LTD. market cap for fiscal 2025 was $1.4B.